Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure

Description

This study evaluates the use of a wearable vest capable of non-invasively measuring lung fluid content in hospitalized patients with heart failure

Conditions

Heart Failure; With Decompensation

Talk to us

Study Overview

On this page

Study Details

Study overview

This study evaluates the use of a wearable vest capable of non-invasively measuring lung fluid content in hospitalized patients with heart failure

Remote Dielectric Sensing Technology Guided Diuresis in Hospitalized Patients With Acute Decompensated Heart Failure

Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure

Condition
Heart Failure; With Decompensation
Intervention / Treatment

-

Contacts and Locations

San Francisco

University of California, San Francisco, San Francisco, California, United States, 94143

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients hospitalized for acute decompensated heart failure requiring treatment with intravenous diuretics and/or IV vasoactive drugs
  • * Patient has signed informed consent and has authorized use and disclosed health information
  • * Patient is at least 18 years of age
  • * Patient physically suitable for ReDS measurement
  • * GFR\>25
  • * Initial ReDS Measurement \>35%
  • * Patient characteristics excluded from approved use of ReDS system: height less than 155cm or greater than 190cm, BMI \<22 or \>39, chest circumference \<80cm or \>115cm , or flail chest
  • * Evidence of focal lung lesions on history, physical exam or chest x-ray, including history of pulmonary embolism, active pneumonia, or known lung nodule
  • * Chronic renal failure (GFR\<25)
  • * Prior cardiac surgery within 2 months of index admission
  • * Patient has a ventricular assist device or has had a cardiac transplantation
  • * Patients in cardiogenic shock at admission requiring inotropic support
  • * Congenital heart malformations or intra-thoracic mass that would affect right-lung anatomy (e.g dextrocardia, lung carcinoma, or pacemaker box in the right chest)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Francisco,

Liviu Klein, MD, MS, PRINCIPAL_INVESTIGATOR, Director, Mechanical Circulatory Support and Heart Failure Device Program

Study Record Dates

2025-12-31